Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

Research and Innovation Action · Running

AI-POD Trustworthy AI Tools for the Prediction of Obesity Related Vascular Diseases

Coordinator
Medizinische Universitaet Wien, Austria
Runs
1 May 2023 to 30 April 2027
Status
Running
EU funding
€5.3m
Total cost
€5.3m
Partners
13 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101080302

What the project is doing

In the project's own words, from its summary on CORDIS.

Weight problems and obesity are increasing at a rapid rate already concerning more than 436mio people in European countries. Obese persons have a 50% higher risk of cardio-vascular disease (CVD) mortality and treatment costs result in a total economic burden of over 210 billion Euro per year. To date the prediction of the individual risk for major adverse CVD events in the obese patient population is a challenge. Current risk scores are not sufficiently accurate and there is no implementation of scores into user friendly solutions.

The AI-POD project aims to reduce the number of CVD related deaths in Europe by developing an AI-based risk prediction score to support clinical decision making and by equipping obese persons with trustworthy AI tools. AI tools will integrate clinical, laboratory and imaging data to translate disease risk into actionable health information to guide diagnostic steps and treatment recommendations. The tools will be validated in six clinical sites on CVD and serve as the basis for a lasting interdisciplinary platform for distributed learning in other vascular territories.

AI-POD will push the boundaries of clinical insight in CVD in obese persons, including its treatment and risk management. AI-POD main outcomes are (1) a novel imaging-based AI-based risk score and Clinical Decision Support System (CDSS) for the risk assessment and prediction of obesity-related CVD and associated complications as a pre-requiste for further AI-based prevention and treatment management; (2) an innovative, easy-to-use mobile app for citizens (Citizen App) that interacts with the CDSS empowering obese people to better monitor and manage their own health.

Physicians will benefit from more efficient workflows and in consequence, public health budgets will be unburdened by reducing morbidity and mortality of obese indiviudals.

Who is involved

OrganisationCityCountryRole
Medizinische Universitaet WienWienAustriaCoordinator
Eibir Gemeinnutzige GmbH Zur Forderung Der Erforschung Der Biomedizinischen BildgebungWienAustriaParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Universitat ZurichZurichSwitzerlandAssociatedpartner
Univerzita KarlovaPraha 1CzechiaParticipant
Medicalvalues GmbHKarlsruheGermanyParticipant
Ruhr-Universitaet BochumBochumGermanyParticipant
Ruprecht-Karls-Universitaet HeidelbergHeidelbergGermanyParticipant
Universitatsklinikum BonnBonnGermanyParticipant
Semmelweis EgyetemBudapestHungaryAssociatedpartner
Brightfish BVHoofddorpNetherlandsParticipant
Collective Minds Radiology ABDanderydSwedenParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI